A

Aligos Therapeutics

85 employees

Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

Basic info

biotechnology research

Biotechnology

2018

$125M

from 8 investors over 8 rounds

A

Aligos Therapeutics raised $125M on January 10, 2020

Investors: Vivo Capital, Logos Global Management, LP, Versant Ventures, Novo Holdings and Wellington Management

A

Aligos Therapeutics raised $100M on January 1, 2018

Investors: Novo Holdings, Versant Ventures and Vivo Capital